[ad_1] (Reuters) — Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen and Japan’s SoftBank, on Friday filed for an initial public offering of its shares in New York. The…
[ad_1] (Reuters) — Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen and Japan’s SoftBank, on Friday filed for an initial public offering of its shares in New York. The…